Exabis Library
Welcome to the e-CCO Library!
P228: Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P228: Ultrasound for assessing disease activity in ulcerative colitis: Development of a novel ultrasonographic disease activity index
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P229 PillCamCrohn’sCapsule: the use of a panenteric capsule endoscopy in a Portuguese centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P229: Capsule endoscopy is useful in the diagnosis and monitoring of postoperative recurrence in Crohn’s disease. Analysis from an 11-year cohort.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P229: Comparison of the characteristics of segmental mucosal microbiome according to the extent of inflammation in ulcerative colitis.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P229: Evidence of content validity and psychometric properties of SF-36 for measuring health-related quality of life of patients with Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P229: Standardization of Quantum Blue® rapid TDM assays with WHO international standards for adalimumab and infliximab
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P229: The modified postoperative endoscopic recurrence score for Crohn's disease: Does it really make a difference in predicting clinical recurrence?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P229: The new biosimilar of infliximab SB2 can be quantified by IFX-optimised therapeutic drug monitoring assays
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P229: The relationship between computed tomography enterography findings and levels of faecal biomarkers in patients with small bowel Crohn’s disease: A prospective study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P230 Health-related quality of life in adolescents and young adults (AYA) with inflammatory bowel disease and its correlations with demographic, clinical, laboratory and therapeutic evaluations
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P230: A first pregnancy seems associated with a positive effect on the course of inflammatory bowel disease: Data from a prospective pregnancy cohort
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P230: Adalimumab in Crohn's disease is protective against periodontitis based on a validated oral health questionnaire
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P230: Development of a Japanese version of the IBD Self-Efficacy Scale and evaluation of its current status in Japan
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P230: Elevated angiopoietins independent of TNF α regulation appear to play a key role in immune mediated angiogenesis in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P230: Methotrexate in the treatment of Crohn's disease: a Portuguese real-life single center experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P230: Prediction of loss of response to anti-TNF therapy using SES-CD in patients with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P230: Ultrasonography-based and Magnetic Resonance-based Lémann Index: two sides of the same coin
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P231 Epidemiological profile and long-term outcomes from a large PSC-IBD cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P231: Backgrounds and D-dimer on admission are useful factors for predicting venous thromboembolic complications in hospitalized patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM